These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10585620)

  • 1. Insulin pump therapy in type 1 pediatric patients: now and into the year 2000.
    Kaufman FR; Halvorson M; Miller D; Mackenzie M; Fisher LK; Pitukcheewanont P
    Diabetes Metab Res Rev; 1999; 15(5):338-52. PubMed ID: 10585620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pump therapy in childhood diabetes mellitus: guidelines for use.
    Tamborlane WV; Fredrickson LP; Ahern JH
    Treat Endocrinol; 2003; 2(1):11-21. PubMed ID: 15871551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
    Pickup J; Keen H
    Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic ketoacidosis in pregnancy resulting from insulin pump failure. A case report.
    Lindenbaum C; Menzin A; Ludmir J
    J Reprod Med; 1993 Apr; 38(4):306-8. PubMed ID: 8501740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents.
    Hanas R; Ludvigsson J
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():32-8. PubMed ID: 16774616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion in patients with diabetes mellitus.
    Schiel R
    Ther Apher Dial; 2003 Apr; 7(2):232-7. PubMed ID: 12918949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pump therapy in type 1 diabetes mellitus.
    Liberatore Rdel R; Damiani D
    J Pediatr (Rio J); 2006; 82(4):249-54. PubMed ID: 16912828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin pump therapy: indications and risks - Case 7/2010].
    Ketterer C; Müssig K; Gerstenecker AK; Fritsche A
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1617. PubMed ID: 20730708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
    Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
    Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and Relevance of Insulin Pump Therapy in the Aetiology of Ketoacidosis in People with Type 1 Diabetes.
    Giessmann LC; Kann PH
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):745-751. PubMed ID: 30049002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
    Realsen J; Goettle H; Chase HP
    Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.